During the past decade, Retinal Consultants Medical Group, Inc. conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 19 clinical trials were completed, i.e. on average, 38.8% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 14 clinical trials were completed. i.e. 45.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retinal Consultants Medical Group, Inc." #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Genentech, Inc." with 7 trials sponsored, "Kodiak Sciences Inc" with 5 trials sponsored, "Clearside Biomedical, Inc." with 3 trials sponsored and "ThromboGenics" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retinal Consultants Medical Group, Inc." #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "California Retina Consultants" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Milton S. Hershey Medical Center" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Retinal Consultants Medical Group, Inc." are "Diabetic Macular Edema" (12 trials), "Geographic Atrophy" (9 trials), "Macular Degeneration" (7 trials), "Diabetic Retinopathy" (6 trials) and "Neovascular Age-related Macular Degeneration" (4 trials). Many other conditions were trialed in "Retinal Consultants Medical Group, Inc." in a lesser frequency.

Most popular intervention types in "Retinal Consultants Medical Group, Inc." are "Drug" (53 trials), "Other" (14 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (10 trials), "Aflibercept" (9 trials), "Faricimab" (6 trials), "Ranibizumab" (6 trials) and "KSI-301" (5 trials). Other intervention names were less common.

The vast majority of trials in "Retinal Consultants Medical Group, Inc." are 60 trials for "All" genders.

Currently, there are NaN active trials in "Retinal Consultants Medical Group, Inc.". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Retinal Consultants Medical Group, Inc., undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Retinal Consultants Medical Group, Inc., 7 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".